| Product Code: ETC9625293 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Neurological Biomarkers Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Neurological Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Neurological Biomarkers Market - Industry Life Cycle |
3.4 Taiwan Neurological Biomarkers Market - Porter's Five Forces |
3.5 Taiwan Neurological Biomarkers Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan Neurological Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Taiwan Neurological Biomarkers Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Taiwan Neurological Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Taiwan |
4.2.2 Growing awareness and emphasis on early diagnosis and treatment |
4.2.3 Technological advancements in biomarker research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for biomarker approval |
4.3.2 Limited reimbursement policies for neurological biomarker tests |
4.3.3 High costs associated with biomarker research and development |
5 Taiwan Neurological Biomarkers Market Trends |
6 Taiwan Neurological Biomarkers Market, By Types |
6.1 Taiwan Neurological Biomarkers Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Neurological Biomarkers Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Taiwan Neurological Biomarkers Market Revenues & Volume, By Genomic Biomarkers, 2021- 2031F |
6.1.4 Taiwan Neurological Biomarkers Market Revenues & Volume, By Proteomic Biomarkers, 2021- 2031F |
6.1.5 Taiwan Neurological Biomarkers Market Revenues & Volume, By Metabolomic Biomarkers, 2021- 2031F |
6.1.6 Taiwan Neurological Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F |
6.1.7 Taiwan Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Taiwan Neurological Biomarkers Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Neurological Biomarkers Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.2.3 Taiwan Neurological Biomarkers Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.2.4 Taiwan Neurological Biomarkers Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.5 Taiwan Neurological Biomarkers Market Revenues & Volume, By Autism Spectrum Disorders, 2021- 2031F |
6.2.6 Taiwan Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Taiwan Neurological Biomarkers Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Neurological Biomarkers Market Revenues & Volume, By Hospital Laboratories, 2021- 2031F |
6.3.3 Taiwan Neurological Biomarkers Market Revenues & Volume, By Clinical Diagnostic Centers, 2021- 2031F |
6.3.4 Taiwan Neurological Biomarkers Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.3.5 Taiwan Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan Neurological Biomarkers Market Import-Export Trade Statistics |
7.1 Taiwan Neurological Biomarkers Market Export to Major Countries |
7.2 Taiwan Neurological Biomarkers Market Imports from Major Countries |
8 Taiwan Neurological Biomarkers Market Key Performance Indicators |
8.1 Adoption rate of neurological biomarker testing in clinical practice |
8.2 Number of research studies and publications on neurological biomarkers in Taiwan |
8.3 Investment in RD for new neurological biomarkers |
8.4 Collaboration and partnerships between academia, industry, and government for biomarker research and development |
8.5 Number of patents filed for novel neurological biomarkers. |
9 Taiwan Neurological Biomarkers Market - Opportunity Assessment |
9.1 Taiwan Neurological Biomarkers Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan Neurological Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Taiwan Neurological Biomarkers Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Taiwan Neurological Biomarkers Market - Competitive Landscape |
10.1 Taiwan Neurological Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Neurological Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here